Adaptive Biotechnologies Corp

Ownership Transactions Reported by 22 Insiders

Symbol
ADPT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1165 Eastlake Ave E, Seattle, Washington

Insiders trading volume in the past year

Adaptive Biotechnologies Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Chad M. Robins CEO and Chairman, Director $8.84M -$167K -1.85% Mar 4, 2024
Harlan S. Robins Chief Scientific Officer $3.51M Mar 4, 2024
Tycho Peterson Chief Financial Officer $1.83M -$53.2K -2.83% Mar 4, 2024
Julie Rubinstein President $1.68M -$136K -7.46% Mar 4, 2024
Sharon Benzeno Chief Commercial Ofc Imm Med $1.13M -$101K -8.23% Mar 4, 2024
Nitin Sood Chief Commercial Officer, MRD $887K Aug 7, 2023
Francis Lo Chief People Officer $881K -$50.4K -5.41% Mar 4, 2024
Susan Bobulsky Chief Commercial Officer, MRD $854K -$44.6K -4.97% Mar 4, 2024
R. Mark Adams Chief Operating Officer $724K Apr 10, 2023
Stacy L. Taylor SVP and General Counsel $627K -$167K -21% Aug 22, 2024
Peter M. Neupert Director $581K Mar 12, 2024
Kyle Piskel Chief Financial Officer $530K -$27.6K -4.94% May 15, 2024
Robert Hershberg Director $368K Mar 4, 2024
Katey Einterz Owen Director $196K Mar 4, 2024
Michael J. Pellini Director $186K Mar 4, 2024
Michelle Renee Griffin Director $178K Mar 4, 2024
Henning Thorsen SVP, Commercial Operations $120K May 17, 2021
Leslie Trigg Director $107K Mar 6, 2023
Kevin T. Conroy Director $94.9K Mar 6, 2023
Chad M. Cohen Chief Financial Officer $89.2K Dec 22, 2021
Lance Baldo Chief Medical Officer $70.9K Mar 8, 2022
Jyoti Palaniappan SVP, Diagnostics, T-Detect $37.8K Jul 19, 2021

Recent Insider Transactions by Companies or Individuals for Adaptive Biotechnologies Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.